FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation.

Oxidative Medicine and Cellular Longevity
Xiaowei WangShoujun Bai

Abstract

Diabetic nephropathy (DN) is the most common cause of end-stage renal disease. Although numerous reports have demonstrated a correlation between epithelial-mesenchymal transition (EMT) and renal fibrosis, how these processes lead to tubular dysfunction remains unclear. Here, we show that FOXO3a protects kidneys from injury in type II DN by increasing Sirt6 expression, which deacetylates Smad3 and inhibits its transcriptional activity. The results showed that progressive EMT in the kidneys from db/db mice is associated with Sirt6 downregulation and involved in tubular injury and dysfunction. The reduction of Sirt6 levels in db/db mice resulted in progressive kidney injury, indicating the protective role of Sirt6. Furthermore, Sirt6 was shown to directly bind to Smad3, a key downstream mediator of TGF-β, and could deacetylate it to inhibit its nuclear accumulation and transcriptional activity in HK2 cells. Besides, we demonstrate that FOXO3a activates Sirt6 expression by binding to its promoter. shRNA-induced FOXO3a knockdown in the kidneys of db/db mice exacerbated tubular injury and renal function loss. Mechanistically, FOXO3a protects against kidney injury in type II DN through the Sirt6/Smad3 axis. Thus, the pharmacological t...Continue Reading

References

May 28, 2003·Biochemical and Biophysical Research Communications·Masaki FujimotoSeijiro Mori
Sep 15, 2005·American Journal of Physiology. Renal Physiology·Jürgen M BohlenderGunter Wolf
Jan 28, 2006·Cell·Raul MostoslavskyFrederick W Alt
Mar 30, 2007·The American Journal of Pathology·Volha NinichukHans-Joachim Anders
May 5, 2007·The Journal of Biological Chemistry·Andrea W Tu, Kunxin Luo
Mar 20, 2010·Journal of the American Society of Nephrology : JASN·Marie-Luise BrezniceanuJohn S D Chan
Jul 16, 2011·Cytokine & Growth Factor Reviews·Claire E Hills, Paul E Squires
Mar 1, 2012·Nature·Yariv KanfiHaim Y Cohen
Nov 7, 2012·Clinical Science·Xiao-Ming MengHui Y Lan
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Mar 26, 2014·Biomarkers in Medicine·Stephen J McWilliamMunir Pirmohamed
Oct 29, 2015·Kidney International·Punithavathi RanganathanGanesan Ramesh
Dec 25, 2015·Journal of the American Society of Nephrology : JASN·Koji TakaoriMotoko Yanagita
Oct 24, 2017·Cell Metabolism·Marcos Rios GarciaMauricio Berriel Diaz
Feb 6, 2018·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kausik Umanath, Julia B Lewis
Feb 11, 2018·Seminars in Cancer Biology·Zhiqiang MaFulin Chen
Mar 4, 2020·International Journal of Oncology·Zhen DongHongjuan Cui
Apr 20, 2020·Cellular and Molecular Gastroenterology and Hepatology·Xiaolin ZhongX Charlie Dong
Jun 15, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jinhang ZhangJinhan He
Aug 14, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiaowen ChenHaibo Long

❮ Previous
Next ❯

Software Mentioned

ImageJ
Image
GraphPad
Pro Plus
Prism

Related Concepts

Related Feeds

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.